UB Paderborn / Katalog / Suche / in CDI

Enhanced novelty-induced corticosterone spike and upregulated serotonin 5-HT1A and cannabinoid CB1 receptors in adolescent BTBR mice

Psychoneuroendocrinology, 2014-01, Vol.39, p.158-169

2014

Volltextzugriff (PDF)

Sensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient mice

The international journal of neuropsychopharmacology, 2013-04, Vol.16 (3), p.631-645

2013

Volltextzugriff (PDF)

The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulation

Molecular cancer therapeutics, 2014-10, Vol.13 (10), p.2253-2263

2014

Volltextzugriff (PDF)

Optimising the combination dosing strategy of abemaciclib and vemurafenib in BRAF-mutated melanoma xenograft tumours

British journal of cancer, 2016-03, Vol.114 (6), p.669-679

2016

Volltextzugriff (PDF)

Interleukin-1beta Causes Fluoxetine Resistance in an Animal Model of Epilepsy-Associated Depression

Neurotherapeutics, 2012-04, Vol.9 (2), p.477-485

2012

Volltextzugriff (PDF)

Autoreceptor‐mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment

Journal of neurochemistry, 2004-11, Vol.91 (3), p.683-693

2004

Volltextzugriff (PDF)

Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice

Progress in neuro-psychopharmacology & biological psychiatry, 2012-08, Vol.38 (2), p.260-269

2012

Volltextzugriff (PDF)

Plasticity of Presynaptic and Postsynaptic Serotonin 1A Receptors in an Animal Model of Epilepsy-Associated Depression

Neuropsychopharmacology (New York, N.Y.), 2011-05, Vol.36 (6), p.1305-1316

2011

Volltextzugriff (PDF)

Hippocampal serotonin-1A receptor function in a mouse model of anxiety induced by long-term voluntary wheel running

Synapse (New York, N.Y.), 2013-10, Vol.67 (10), p.648-655

2013

Volltextzugriff (PDF)

Abstract 282: Pan-RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4 and 6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.282-282

2016

Volltextzugriff (PDF)

Serotonin‐1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline

Journal of neurochemistry, 2008-05, Vol.105 (4), p.1091-1099

2008

Volltextzugriff (PDF)

GABAB receptor-positive modulators: brain region-dependent effects

The Journal of pharmacology and experimental therapeutics, 2012-01, Vol.340 (1), p.19

2012

Volltextzugriff (PDF)

Differential regulation of serotonin-1A receptor-stimulated [ 35S]GTPγS binding in the dorsal raphe nucleus by citalopram and escitalopram

European journal of pharmacology, 2008-03, Vol.583 (1), p.103-107

2008

Volltextzugriff (PDF)

Density and function of central serotonin (5‐HT) transporters, 5‐HT1A and 5‐HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior

Journal of neurochemistry, 2011-01, Vol.116 (2), p.291-303

2011

Volltextzugriff (PDF)

The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridines

Molecular cancer therapeutics, 2004-01, Vol.3 (1), p.1-9

2004

Volltextzugriff (PDF)

Abstract LB-122: LY2835219, a selective inhibitor of CDK4 and CDK6, inhibits growth in preclinical models of human cancer

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.LB-122-LB-122

2013

Volltextzugriff (PDF)

Hippocampal serotonin-1A receptor function in a mouse model of anxiety induced by long-term voluntary wheel running: 5-HT 1A Receptors and Irradiation

Synapse (New York, N.Y.), 2013-10, Vol.67 (10), p.648-655

2013

Volltextzugriff (PDF)

Sensitivity of hippocampal 5-HT sub(1A) receptors to mild stress in BDNF-deficient mice

The international journal of neuropsychopharmacology, 2013-04, Vol.16 (3), p.631-645

2013

Volltextzugriff (PDF)

Abstract C88: The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulation

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.C88-C88

2013

Volltextzugriff (PDF)

Plasticity of Presynaptic and Postsynaptic Serotonin IA Receptors in an Animal Model of Epilepsy-Associated Depression

Neuropsychopharmacology (New York, N.Y.), 2011, Vol.36 (6), p.1305-1316

2011

Volltextzugriff (PDF)

Abstract A108: LY2606368, a second generation Chk1 inhibitor, inhibits growth of ovarian carcinoma xenografts either as monotherapy or in combination with standard-of-care agents

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.A108-A108

2011

Volltextzugriff (PDF)

Identification of a BRCA1-associated kinase with potential biological relevance

Oncogene, 1998-02, Vol.16 (8), p.1031-1040

1998

Volltextzugriff (PDF)

Density and function of central serotonin (5-HT) transporters, 5-HT1Aand 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior

Journal of neurochemistry, 2011, Vol.116 (2), p.291-303

2011

Volltextzugriff (PDF)

Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior: Central 5-HT regulation and social behavior in BTBR mice

Journal of neurochemistry, 2011-01, Vol.116 (2), p.291-303

2011

Volltextzugriff (PDF)

Differential mechanisms of desensitization of 5‐HT1A receptors in the dorsal raphe nucleus (DRN) following chronic treatment with selective serotonin reuptake inhibitors (SSRIs)

The FASEB journal, 2007, Vol.21 (6), p.A1179-A1179

2007

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Enhanced novelty-induced corticosterone spike and upregulated serotonin 5-HT1A and cannabinoid CB1 receptors in adolescent BTBR mice

Sensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient mice

The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulation

Optimising the combination dosing strategy of abemaciclib and vemurafenib in BRAF-mutated melanoma xenograft tumours

Interleukin-1beta Causes Fluoxetine Resistance in an Animal Model of Epilepsy-Associated Depression

Autoreceptor‐mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment

Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice

Plasticity of Presynaptic and Postsynaptic Serotonin 1A Receptors in an Animal Model of Epilepsy-Associated Depression

Hippocampal serotonin-1A receptor function in a mouse model of anxiety induced by long-term voluntary wheel running

Abstract 282: Pan-RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4 and 6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1

Serotonin‐1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline

GABAB receptor-positive modulators: brain region-dependent effects

Differential regulation of serotonin-1A receptor-stimulated [ 35S]GTPγS binding in the dorsal raphe nucleus by citalopram and escitalopram

Density and function of central serotonin (5‐HT) transporters, 5‐HT1A and 5‐HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior

The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridines

Abstract LB-122: LY2835219, a selective inhibitor of CDK4 and CDK6, inhibits growth in preclinical models of human cancer

Hippocampal serotonin-1A receptor function in a mouse model of anxiety induced by long-term voluntary wheel running: 5-HT 1A Receptors and Irradiation

Sensitivity of hippocampal 5-HT sub(1A) receptors to mild stress in BDNF-deficient mice

Abstract C88: The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulation

Plasticity of Presynaptic and Postsynaptic Serotonin IA Receptors in an Animal Model of Epilepsy-Associated Depression

Abstract A108: LY2606368, a second generation Chk1 inhibitor, inhibits growth of ovarian carcinoma xenografts either as monotherapy or in combination with standard-of-care agents

Identification of a BRCA1-associated kinase with potential biological relevance

Density and function of central serotonin (5-HT) transporters, 5-HT1Aand 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior

Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior: Central 5-HT regulation and social behavior in BTBR mice

Differential mechanisms of desensitization of 5‐HT1A receptors in the dorsal raphe nucleus (DRN) following chronic treatment with selective serotonin reuptake inhibitors (SSRIs)

Suchergebnisse filtern